Abstract 3737: Severe Obesity and Colorectal Cancer Patient Survival

Carrie R. Daniel,Xiang Shu,Yuanqing Ye,Jian Gu,G. S. Raju,Scott Kopetz,Xifeng Wu
DOI: https://doi.org/10.1158/1538-7445.am2015-3737
IF: 11.2
2015-01-01
Cancer Research
Abstract:Abstract Background: More than one-third of all U.S. adults are obese (BMI >30); and 15% of middle-aged adults, the group most commonly diagnosed and treated for colorectal and other cancers, meet the criteria for class II obesity (BMI> = 35). In contrast to the large and consistent body of evidence for obesity and increased colorectal cancer risk, several recent meta-analyses indicate that the association with colorectal patient survival is poorly defined. Some evidence suggests that moderate adiposity may be protective. In a prospective cohort of well-characterized CRC patients, we evaluated class I and class II obesity in relation to 5-year and 10-year survival outcomes. Methods: Histologically-confirmed colorectal adenocarcinoma patients (n = 634) evaluated at the University of Texas MD Anderson Cancer Center were followed for a median period of 4 years. We collected epidemiological data through questionnaires and abstracted treatment, anthropometric, and clinicopathologic data from patients’ electronic medical records. Overall survival (OS) and progression/recurrence-free survival (PFS) were calculated from the date of pathologic diagnosis until disease progression, first recurrence, or death. Hazard ratios (HRs) and 95% confidence intervals (CIs) were estimated in multivariable Cox proportional hazards models adjusted for demographics, lifestyle factors, tumor characteristics, and treatment modality. Results: We observed a 1.5-fold increased risk of death among class II obese (BMI> = 35), as compared to overweight CRC patients in multivariable-adjusted models. Among patients who reported stable weight and among stage I-III patients, the association between class II obesity and OS was more pronounced [BMI> = 35 vs. BMI 25-29.9 (ref), HR and 95% CI: 3.49 (1.68-7.22) and 2.40 (1.33-4.31), respectively], but no associations were observed among metastatic patients or among patients who experienced recent weight loss. Similar associations were observed with PFS, but few reached statistical significance. Conclusions: Severe adiposity defined as class II obesity (BMI > = 35) was associated with significantly higher mortality among CRC patients. Clarifying what is not a healthy weight for cancer patients and survivors remains both a clinically relevant and timely concern. Understanding and targeting this relationship may improve long-term outcomes among growing numbers of obese patients and cancer survivors. Citation Format: Carrie R. Daniel, Xiang Shu, Yuanqing Ye, Jian Gu, G. S. Raju, Scott Kopetz, Xifeng Wu. Severe obesity and colorectal cancer patient survival. [abstract]. In: Proceedings of the 106th Annual Meeting of the American Association for Cancer Research; 2015 Apr 18-22; Philadelphia, PA. Philadelphia (PA): AACR; Cancer Res 2015;75(15 Suppl):Abstract nr 3737. doi:10.1158/1538-7445.AM2015-3737
What problem does this paper attempt to address?